{
    "medicine_id": "5693585e63e7e3508b4afd55b5c9a94da200d91a",
    "platform_id": "DB13164",
    "metadata": {
        "name": "Pastilles Valda 2 mg Tablet coated",
        "composition": "2 mg Olmutinib",
        "clinical_particulars": {
            "therapeutic_indications": "For use in treatment of metastatic T790M mutation positive non small cell lung cancer A19196",
            "contraindications": {
                "disease": "No toxicological investigation has been completed",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Olmutinib selectively and irreversibly binds and inhibits epidermal growth factor receptors EGFR with the T790M activating mutation EGFRs are frequently over expressed in lung cancer and contribute to activation of the phosphoinositide 3 kinase and mitogen activated protein kinase pathways which both promote cell survival and proliferation A19200 A19202 By inhibiting EGFR activation olmutinib attenuates the activation of these tumor promoting pathways",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olmutinib"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olmutinib"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Olmutinib"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Olmutinib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}